Pharma News, 2016

KENILWORTH, N.

PARIS—French drug maker Sanofi SA said Tuesday it planned to invest €300 million ($339 million) to expand its manufacturing site for biological drugs in Belgium.

Valeant CEO Michael Pearson spent long hours under questioning in Washington, DC, on Monday as a Senate committee continued its probe of the company’s pricing policies.

Mabthera, when used outside the intended indications, rheumatoid arthritis and lymphoma, is more effective than one of the more recent drugs for multiple sclerosis.

The world’s largest health imaging study, funded by the Medical Research Council, Wellcome Trust, and the British Heart Foundation is launched today.

Teva ($TEVA) is expecting to close on its buyout of Allergan’s generic drug business, but for now Actavis is still Allergan’s, for better or worse.

Phthalates may be hitching a ride on your Big Mac.

In a huge immunization effort in 150 countries, health teams will on Sunday launch what they hope will be the final push against polio.

COLUMBIA, S.

Global buyout firm Advent International and U.

The US Food and Drug Administration (FDA) has accepted Merck's supplemental biologics license application for Keytruda (pembrolizumab) in recurrent or metastatic head and neck canc...

Medivation Inc.